Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Efficacy and Safety of a Beet-Derived Inorganic Nitrate-Based Food Product for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of a beet-derived inorganic nitrate-based product to prevent contrast-induced nephropathy in high-risk pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beet-derived inorganic nitrate-based food product

Snippet

Sponsor: National Medical Research Center for Therapy and Preventive Medicine | Conditions: Contrast-induced Nephropathy Following Percutaneous Intervention (CIN) | NA | Status: RECRUITING